Washington Trust Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
43,407
-1,876
-4% -$49.1K 0.08% 114
2026
Q1
$1.27M Buy
45,283
+30
+0.1% +$799 0.1% 102
2025
Q4
$1.13M Buy
45,253
+533
+1% +$13.4K 0.09% 108
2025
Q3
$1.14M Hold
44,720
0.09% 111
2025
Q2
$1.08M Sell
44,720
-2,817
-6% -$65.7K 0.09% 98
2025
Q1
$1.2M Sell
47,537
-607
-1% -$15.9K 0.11% 90
2024
Q4
$1.28M Sell
48,144
-1,072
-2% -$29.1K 0.11% 90
2024
Q3
$1.42M Buy
49,216
+360
+0.7% +$10.5K 0.12% 85
2024
Q2
$1.37M Sell
48,856
-807
-2% -$22.2K 0.13% 81
2024
Q1
$1.38M Sell
49,663
-7,163
-13% -$199K 0.13% 80
2023
Q4
$1.64M Buy
56,826
+598
+1% +$18.1K 0.16% 73
2023
Q3
$1.87M Buy
56,228
+4,362
+8% +$154K 0.19% 73
2023
Q2
$1.9M Sell
51,866
-2,506
-5% -$97.5K 0.18% 73
2023
Q1
$2.22M Buy
54,372
+4,357
+9% +$188K 0.23% 67
2022
Q4
$2.56M Hold
50,015
0.28% 65
2022
Q3
$2.19M Hold
50,015
0.2% 79
2022
Q2
$2.62M Sell
50,015
-3,805
-7% -$194K 0.23% 77
2022
Q1
$2.79M Sell
53,820
-300
-0.6% -$15.6K 0.2% 81
2021
Q4
$3.2M Buy
+54,120
New +$2.68M 0.22% 75

Other funds holding PFE

Washington Trust Advisors's PFE Position: Q2 2026 in Review

Washington Trust Advisors reduced its Pfizer (PFE) stake by 4.1% in Q2 2026, selling an estimated $49.1K and leaving 43,407 shares worth $1.05M. The position accounts for 0.08% of the portfolio, ranked #114.

Washington Trust Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.2M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Washington Trust Advisors held 43,407 shares of Pfizer worth $1.05M as of Q2 2026.
  • Washington Trust Advisors sold 1,876 Pfizer shares in Q2 2026, an estimated $49.1K.
  • Pfizer made up 0.08% of Washington Trust Advisors's portfolio in Q2 2026, its #114 holding.
  • Washington Trust Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Pfizer position peaked at $3.2M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.